跳至主要内容
临床试验/JPRN-UMIN000046979
JPRN-UMIN000046979已完成未知

A confirmatory study on the effect of continuous intake of test food on bone metabolism. -A placebo-controlled, randomized, double-blind clinical trial- - A confirmatory study on the effect of continuous intake of test food on bone metabolism.

IMEQRD Co., Ltd0 个研究点目标入组 40 人开始时间: 2022年2月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 70years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.Currently undergoing treatment for any disease, or receive medical treatment such as medical drugs or traditional Chinese medicines. Medications used as needed are acceptable. 2.Receiving nutritional and exercise therapy by medical doctors. 3.Have severe diseases or a history of severe diseases. 4.Received hormone replacement therapy within six months before the study. 5.Have experienced bone-related diseases such as bone fracture within six months before the study. 6.Have artificial materials or foreign substances in the bones with surgeries or any reason. 7.Have the Young Adult Mean% less than 70%. 8.Received barium swallow test within 7 days before the day of visit. 9.Have currently been taking commercially available drugs, quasi-drug products, foods, or supplements with any functional claims. However, can discontinue taking these drugs/foods during the trial period is acceptable to join the study. 10.Have allergies to drugs or foods. 11.Planning extremely change lifestyle (such as diet, sleep, or exercise) during the study period. 12.Planning travel to foreign countries during the study period. 13.Taking more than 60 g alcohol/day. 14.Smoking within one year before the trial. 15.Individuals who joined other clinical trials from one month before the trial, individuals who have currently been joined other clinical trials, and also Individuals who are planning to join other clinical trials during the trial. 16.Unsuitable for the study, that judged by the principal investigator.

研究者

发起方
IMEQRD Co., Ltd

相似试验